Cargando…

Optimized furosemide taste masked orally disintegrating tablets

Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS;...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Mohamed Abbas, Abou El Ela, Amal El Sayeh F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681311/
https://www.ncbi.nlm.nih.gov/pubmed/29158715
http://dx.doi.org/10.1016/j.jsps.2017.04.002
_version_ 1783277895669514240
author Ibrahim, Mohamed Abbas
Abou El Ela, Amal El Sayeh F.
author_facet Ibrahim, Mohamed Abbas
Abou El Ela, Amal El Sayeh F.
author_sort Ibrahim, Mohamed Abbas
collection PubMed
description Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s.
format Online
Article
Text
id pubmed-5681311
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56813112017-11-20 Optimized furosemide taste masked orally disintegrating tablets Ibrahim, Mohamed Abbas Abou El Ela, Amal El Sayeh F. Saudi Pharm J Article Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s. Elsevier 2017-11 2017-04-13 /pmc/articles/PMC5681311/ /pubmed/29158715 http://dx.doi.org/10.1016/j.jsps.2017.04.002 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ibrahim, Mohamed Abbas
Abou El Ela, Amal El Sayeh F.
Optimized furosemide taste masked orally disintegrating tablets
title Optimized furosemide taste masked orally disintegrating tablets
title_full Optimized furosemide taste masked orally disintegrating tablets
title_fullStr Optimized furosemide taste masked orally disintegrating tablets
title_full_unstemmed Optimized furosemide taste masked orally disintegrating tablets
title_short Optimized furosemide taste masked orally disintegrating tablets
title_sort optimized furosemide taste masked orally disintegrating tablets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681311/
https://www.ncbi.nlm.nih.gov/pubmed/29158715
http://dx.doi.org/10.1016/j.jsps.2017.04.002
work_keys_str_mv AT ibrahimmohamedabbas optimizedfurosemidetastemaskedorallydisintegratingtablets
AT abouelelaamalelsayehf optimizedfurosemidetastemaskedorallydisintegratingtablets